These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8097617)

  • 1. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Feb; 50(2):300-4. PubMed ID: 8097617
    [No Abstract]   [Full Text] [Related]  

  • 2. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
    Trissel LA; Bready BB
    Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of paclitaxel (Taxol) administration, stability, and compatibility issues.
    Boyle DA; Goldspiel BR
    Clin J Oncol Nurs; 1998 Oct; 2(4):141-5. PubMed ID: 10232160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of paclitaxel and fluconazole during simulated Y-site administration.
    Burm JP; Choi JS; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Nov; 51(21):2704-6. PubMed ID: 7856586
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
    Xu Q; Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
    Trissel LA; Parks NP; Santiago NM
    Am J Hosp Pharm; 1991 Oct; 48(10):2186-9. PubMed ID: 1781478
    [No Abstract]   [Full Text] [Related]  

  • 13. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 16. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.